An Update on the BC-CfE HIV Prevention and Treatment Guidelines and Training Programs

An Update on the BC-CfE HIV Prevention and Treatment Guidelines and Training Programs Webinar Main Objectives:

  1. To provide an update regarding the BC-CfE Guidelines for PEP and PrEP
  2. To provide an update on Therapeutic Guidelines for ARV treatment of Adult HIV infection and drugs available through the BC-CfE
  3. To provide an update on educational online courses and Training for Nurse Practitioners in British Columbia

The webinar will include presentations from:

Marianne Harris MD, CCFP
Clinical Trials Physician
BC Centre for Excellence in HIV/AIDS

Junine Toy, Pharm D
Senior Manager, BC-CfE Drug Treatment Program
Clinical Pharmacy Specialist, St. Paul’s Hospital

Silvia A Guillemi MD
Clinical Professor Department of Family Practice, University of British Columbia
BC-CfE Director of Clinical Education


Cost: Free registration.

Presentations will be followed by a question and answer period where participants will have the opportunity to ask questions and receive real time responses from presenters.

Click to Register

This event will be accredited, and attendees may receive a certificate upon attendance and request.

If you are unable to attend the live webinar it will be recorded and available for viewing on BC-CfE’s Education and Training website at education.cfenet.ubc.ca/webinars.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025